happenings at achiezer
COVID Clarification and Update
January 07, 2021
Dear Community,
There has been a lot of confusion and anxiety lately regarding possible treatment options for Coronavirus (COVID-19), specifically concerning the new vaccines and the use of Monoclonal Antibody Treatment.
Acknowledging that we are not health care providers, we want to update you with the latest information we have regarding these treatments. We will try our best to keep the community updated as soon as we receive additional details.
Vaccines:
Regarding Coronavirus (COVID-19) vaccines, we are working tirelessly and extremely close with the NYC Department of Health, The Village of Lawrence, New York State and Northwell Health to set up community vaccination sites as soon as possible.
We understand the anxiety levels of numerous elderly community members and others with pre-existing conditions and are doing everything in our power to accelerate this process. Though vaccines are not yet available to the general public, we will keep the community informed as soon as they are.
Bamlanivimab /Monoclonal Antibody Treatment:
With regards to Monoclonal Antibody Treatment, which has been shown to be highly effective, below is a list of local hospitals that offer this treatment at their outpatient infusion centers, together with numbers to call to schedule an appointment.
Additionally, the general criteria to be eligible for monoclonal antibodies is listed below.
Note that each hospital's criteria may vary slightly and advance registration is required. It is therefore preferable that one's physician contact these centers if they fit general criteria to confirm eligibility for treatment and schedule the appointment.
* Northwell Health North Shore University Hospital (516) 918-6089
* Mt. Sinai South Nassau (516) 632-4998
* Maimonides Medical Center- ER walk-in only
* New York Community Hospital- ER walk-in only
* ODA-Wallabout Health Center (Williamsburg) call (718) 260-4600 (9AM-5PM) to make an appointment
* Ezra Medical Center (Boro Park) call (718) 686-2006 (9AM-5PM) to make an appointment
General Criteria for Monoclonal Antibody Treatment:
Monoclonal Antibody Treatment has been approved for mild to moderate COVID-19 for adults and pediatric patients who meet all of the following criteria:
* positive results of direct SARS-CoV-2 viral testing (it is recommended to be administered as soon as possible after positive viral test for SARS-CoV-2 and within 10 days of symptom onset)
* 12 years of age and older
* weighing at least 40 kg (about 88 lbs)
* high risk patients
High risk is defined as patients who meet at least one of the following criteria:
* Body mass index (BMI) ≥35
* Chronic kidney disease
* Diabetes
* Immunosuppressive disease
* Currently receiving immunosuppressive treatment
* ≥ 65 years of age
* ≥55 years of age AND have
1. cardiovascular disease, or
2. hypertension, or
3. chronic obstructive pulmonary disease/other chronic respiratory disease.
* 12-17 years of age AND have
1. BMI ≥85th percentile for their age and gender-based on CDC growth charts (https://www.cdc.gov/growthcharts/clinical_charts.htm), or
2. sickle cell disease, or
3. congenital or acquired heart disease, or
4. neurodevelopmental disorders, for example, cerebral palsy, or
5. a medical-related technological dependence, for example, tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID-19), or
6. asthma, reactive airway or other chronic respiratory disease that requires daily medication for control.
Monoclonal Antibodies are not authorized for use in patients who are:
* Hospitalized due to COVID-19, or
* Requiring oxygen therapy due to COVID-19, or
* Requiring an increase in baseline oxygen flow rate due to COVID-19, for those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity.
For additional questions regarding these treatments or any hospital-based support needs, please email mschorr@achiezer.org
Wishing the entire community a safe and healthy weekend.
There has been a lot of confusion and anxiety lately regarding possible treatment options for Coronavirus (COVID-19), specifically concerning the new vaccines and the use of Monoclonal Antibody Treatment.
Acknowledging that we are not health care providers, we want to update you with the latest information we have regarding these treatments. We will try our best to keep the community updated as soon as we receive additional details.
Vaccines:
Regarding Coronavirus (COVID-19) vaccines, we are working tirelessly and extremely close with the NYC Department of Health, The Village of Lawrence, New York State and Northwell Health to set up community vaccination sites as soon as possible.
We understand the anxiety levels of numerous elderly community members and others with pre-existing conditions and are doing everything in our power to accelerate this process. Though vaccines are not yet available to the general public, we will keep the community informed as soon as they are.
Bamlanivimab /Monoclonal Antibody Treatment:
With regards to Monoclonal Antibody Treatment, which has been shown to be highly effective, below is a list of local hospitals that offer this treatment at their outpatient infusion centers, together with numbers to call to schedule an appointment.
Additionally, the general criteria to be eligible for monoclonal antibodies is listed below.
Note that each hospital's criteria may vary slightly and advance registration is required. It is therefore preferable that one's physician contact these centers if they fit general criteria to confirm eligibility for treatment and schedule the appointment.
* Northwell Health North Shore University Hospital (516) 918-6089
* Mt. Sinai South Nassau (516) 632-4998
* Maimonides Medical Center- ER walk-in only
* New York Community Hospital- ER walk-in only
* ODA-Wallabout Health Center (Williamsburg) call (718) 260-4600 (9AM-5PM) to make an appointment
* Ezra Medical Center (Boro Park) call (718) 686-2006 (9AM-5PM) to make an appointment
General Criteria for Monoclonal Antibody Treatment:
Monoclonal Antibody Treatment has been approved for mild to moderate COVID-19 for adults and pediatric patients who meet all of the following criteria:
* positive results of direct SARS-CoV-2 viral testing (it is recommended to be administered as soon as possible after positive viral test for SARS-CoV-2 and within 10 days of symptom onset)
* 12 years of age and older
* weighing at least 40 kg (about 88 lbs)
* high risk patients
High risk is defined as patients who meet at least one of the following criteria:
* Body mass index (BMI) ≥35
* Chronic kidney disease
* Diabetes
* Immunosuppressive disease
* Currently receiving immunosuppressive treatment
* ≥ 65 years of age
* ≥55 years of age AND have
1. cardiovascular disease, or
2. hypertension, or
3. chronic obstructive pulmonary disease/other chronic respiratory disease.
* 12-17 years of age AND have
1. BMI ≥85th percentile for their age and gender-based on CDC growth charts (https://www.cdc.gov/growthcharts/clinical_charts.htm), or
2. sickle cell disease, or
3. congenital or acquired heart disease, or
4. neurodevelopmental disorders, for example, cerebral palsy, or
5. a medical-related technological dependence, for example, tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID-19), or
6. asthma, reactive airway or other chronic respiratory disease that requires daily medication for control.
Monoclonal Antibodies are not authorized for use in patients who are:
* Hospitalized due to COVID-19, or
* Requiring oxygen therapy due to COVID-19, or
* Requiring an increase in baseline oxygen flow rate due to COVID-19, for those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity.
For additional questions regarding these treatments or any hospital-based support needs, please email mschorr@achiezer.org
Wishing the entire community a safe and healthy weekend.
Back to previous page
